Logo image of CEVA

CEVA INC (CEVA) Stock Fundamental Analysis

NASDAQ:CEVA - Nasdaq - US1572101053 - Common Stock - Currency: USD

23.56  +0.32 (+1.38%)

After market: 23.56 0 (0%)

Fundamental Rating

5

CEVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CEVA as it has an excellent financial health rating, but there are worries on the profitability. CEVA is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CEVA had positive earnings in the past year.
In the past year CEVA had a positive cash flow from operations.
CEVA had negative earnings in 4 of the past 5 years.
Of the past 5 years CEVA 4 years had a positive operating cash flow.
CEVA Yearly Net Income VS EBIT VS OCF VS FCFCEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CEVA has a worse Return On Assets (-2.15%) than 63.64% of its industry peers.
The Return On Equity of CEVA (-2.48%) is worse than 60.91% of its industry peers.
Industry RankSector Rank
ROA -2.15%
ROE -2.48%
ROIC N/A
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
CEVA Yearly ROA, ROE, ROICCEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

Looking at the Gross Margin, with a value of 87.40%, CEVA belongs to the top of the industry, outperforming 99.09% of the companies in the same industry.
CEVA's Gross Margin has been stable in the last couple of years.
CEVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
CEVA Yearly Profit, Operating, Gross MarginsCEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CEVA has been increased compared to 1 year ago.
Compared to 5 years ago, CEVA has more shares outstanding
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CEVA Yearly Shares OutstandingCEVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CEVA Yearly Total Debt VS Total AssetsCEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CEVA has an Altman-Z score of 9.20. This indicates that CEVA is financially healthy and has little risk of bankruptcy at the moment.
CEVA has a better Altman-Z score (9.20) than 72.73% of its industry peers.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.2
ROIC/WACCN/A
WACC11.63%
CEVA Yearly LT Debt VS Equity VS FCFCEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 7.45 indicates that CEVA has no problem at all paying its short term obligations.
CEVA's Current ratio of 7.45 is amongst the best of the industry. CEVA outperforms 89.09% of its industry peers.
A Quick Ratio of 7.45 indicates that CEVA has no problem at all paying its short term obligations.
CEVA has a Quick ratio of 7.45. This is amongst the best in the industry. CEVA outperforms 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 7.45
Quick Ratio 7.45
CEVA Yearly Current Assets VS Current LiabilitesCEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 860.00% over the past year.
Measured over the past years, CEVA shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.60% on average per year.
The Revenue has grown by 20.23% in the past year. This is a very strong growth!
Measured over the past years, CEVA shows a small growth in Revenue. The Revenue has been growing by 4.17% on average per year.
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%

3.2 Future

The Earnings Per Share is expected to grow by 38.80% on average over the next years. This is a very strong growth
Based on estimates for the next years, CEVA will show a quite strong growth in Revenue. The Revenue will grow by 9.59% on average per year.
EPS Next Y24.61%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CEVA Yearly Revenue VS EstimatesCEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
CEVA Yearly EPS VS EstimatesCEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.08, the valuation of CEVA can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CEVA.
The average S&P500 Price/Earnings ratio is at 27.46. CEVA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 29.42 indicates a quite expensive valuation of CEVA.
The rest of the industry has a similar Price/Forward Earnings ratio as CEVA.
The average S&P500 Price/Forward Earnings ratio is at 36.44. CEVA is around the same levels.
Industry RankSector Rank
PE 49.08
Fwd PE 29.42
CEVA Price Earnings VS Forward Price EarningsCEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CEVA.
Industry RankSector Rank
P/FCF 534.17
EV/EBITDA N/A
CEVA Per share dataCEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CEVA's earnings are expected to grow with 38.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.99
PEG (5Y)N/A
EPS Next 2Y47.11%
EPS Next 3Y38.8%

0

5. Dividend

5.1 Amount

CEVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEVA INC

NASDAQ:CEVA (7/21/2025, 8:00:00 PM)

After market: 23.56 0 (0%)

23.56

+0.32 (+1.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners91.73%
Inst Owner Change-0.3%
Ins Owners3.36%
Ins Owner Change27.65%
Market Cap563.56M
Analysts81.67
Price Target34.68 (47.2%)
Short Float %7.83%
Short Ratio5.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.06%
Min EPS beat(2)-15.97%
Max EPS beat(2)-0.15%
EPS beat(4)2
Avg EPS beat(4)159.87%
Min EPS beat(4)-15.97%
Max EPS beat(4)614.39%
EPS beat(8)3
Avg EPS beat(8)31.07%
EPS beat(12)5
Avg EPS beat(12)15.42%
EPS beat(16)9
Avg EPS beat(16)19%
Revenue beat(2)1
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)3.96%
Revenue beat(4)2
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)13.87%
Revenue beat(8)2
Avg Revenue beat(8)-4.06%
Revenue beat(12)3
Avg Revenue beat(12)-7.15%
Revenue beat(16)7
Avg Revenue beat(16)-3.79%
PT rev (1m)0%
PT rev (3m)-8.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.99%
Valuation
Industry RankSector Rank
PE 49.08
Fwd PE 29.42
P/S 5.16
P/FCF 534.17
P/OCF 164.93
P/B 2.09
P/tB 2.69
EV/EBITDA N/A
EPS(TTM)0.48
EY2.04%
EPS(NY)0.8
Fwd EY3.4%
FCF(TTM)0.04
FCFY0.19%
OCF(TTM)0.14
OCFY0.61%
SpS4.56
BVpS11.25
TBVpS8.74
PEG (NY)1.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.15%
ROE -2.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.4%
FCFM 0.97%
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 58.8%
Cap/Sales 2.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.45
Quick Ratio 7.45
Altman-Z 9.2
F-Score6
WACC11.63%
ROIC/WACCN/A
Cap/Depr(3y)65%
Cap/Depr(5y)55.38%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)860%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%220%
EPS Next Y24.61%
EPS Next 2Y47.11%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue 1Y (TTM)20.23%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%9.85%
Revenue Next Year4.1%
Revenue Next 2Y10.12%
Revenue Next 3Y9.59%
Revenue Next 5YN/A
EBIT growth 1Y48.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.3%
EBIT Next 3Y100.68%
EBIT Next 5YN/A
FCF growth 1Y109.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.82%
OCF growth 3Y-48.76%
OCF growth 5Y-18.53%